Colonial Trust Advisors Moderna, Inc. Transaction History

Colonial Trust Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $853 - $1,154	-10 Reduced 58.82%	7 $0
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $973 - $1,462	14 Added 466.67%	17 $1,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $674 - $886	-7 Reduced 70.0%	3 $0
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $1,066 - $1,444	-9 Reduced 47.37%	10 $1,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $542 - $788	-4 Reduced 17.39%	19 $2,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2,722 - $4,830	23 New	23 $4,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust Advisors with notifications on news.